Matrix protein of Vesicular stomatitis virus harbours a cryptic mitochondrial-targeting motif

References

1. Black B. L., Lyles D. S. 1992; Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo. J Virol 66:4058–4064
   [Google Scholar]
2. Blondel D., Harmison G. G., Schubert M. 1990; Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J Virol 64:1716–1725
   [Google Scholar]
3. Boya P., Pauleau A.-L., Poncet D., Gonzalez-Polo R.-A., Zamzami N., Kroemer G. 2004; Viral proteins targeting mitochondria: controlling cell death. Biochim Biophys Acta 1659178–189 [CrossRef]
   [Google Scholar]
4. Carroll A. R., Wagner R. R. 1979; Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus. J Virol 29:134–142
   [Google Scholar]
5. Cavadini P., Gakh O., Isaya G. 2002; Protein import and processing reconstituted with isolated rat liver mitochondria and recombinant mitochondrial processing peptidase. Methods 26:298–306 [CrossRef]
   [Google Scholar]
6. Clinton G. M., Little S. P., Hagen F. S., Huang A. S. 1978; The matrix (M) protein of vesicular stomatitis virus regulates transcription. Cell 15:1455–1462 [CrossRef]
   [Google Scholar]
7. Everett H., Barry M., Lee S. F., Sun X., Graham K., Stone J., Bleackley R. C., McFadden G. 2000; M11L: a novel mitochondria-localized protein of myxoma virus that blocks apoptosis of infected leukocytes. J Exp Med 191:1487–1498 [CrossRef]
   [Google Scholar]
8. Faria P. A., Chakraborty P., Levay A., Barber G. N., Ezelle H. J., Enninga J., Arana C., van Deursen J., Fontoura B. M. A. 2005; VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Mol Cell 17:93–102 [CrossRef]
   [Google Scholar]
9. Gaddy D. F., Lyles D. S. 2005; Vesicular stomatitis viruses expressing wild-type or mutant M proteins activate apoptosis through distinct pathways. J Virol 79:4170–4179 [CrossRef]
   [Google Scholar]
10. Gaudier M., Gaudin Y., Knossow M. 2002; Crystal structure of vesicular stomatitis virus matrix protein. EMBO J 21:2886–2892 [CrossRef]
    [Google Scholar]
11. Glodowski D. R., Petersen J. M., Dahlberg J. E. 2002; Complex nuclear localization signals in the matrix protein of vesicular stomatitis virus. J Biol Chem 277:46864–46870 [CrossRef]
    [Google Scholar]
12. Gordon D. M., Dancis A., Pain D. 2000; Mechanisms of mitochondrial protein import. Essays Biochem 36:61–73
    [Google Scholar]
13. Harder Z., Zunino R., McBride H. 2004; Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission. Curr Biol 14:340–345 [CrossRef]
    [Google Scholar]
14. Harty R. N., Brown M. E., McGettigan J. P., Wang G., Jayakar H. R., Huibregtse J. M., Whitt M. A., Schnell M. J. 2001; Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. J Virol 75:10623–10629 [CrossRef]
    [Google Scholar]
15. Itoh M., Hotta H., Homma M. 1998; Increased induction of apoptosis by a Sendai virus mutant is associated with attenuation of mouse pathogenicity. J Virol 72:2927–2934
    [Google Scholar]
16. Jacotot E., Ravagnan L., Loeffler M. & 15 other authors 2000; The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med 191:33–46 [CrossRef]
    [Google Scholar]
17. Jayakar H. R., Murti K. G., Whitt M. A. 2000; Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J Virol 74:9818–9827 [CrossRef]
    [Google Scholar]
18. Kopecky S. A., Lyles D. S. 2003a; The cell-rounding activity of the vesicular stomatitis virus matrix protein is due to the induction of cell death. J Virol 77:5524–5528 [CrossRef]
    [Google Scholar]
19. Kopecky S. A., Lyles D. S. 2003b; Contrasting effects of matrix protein on apoptosis in HeLa and BHK cells infected with vesicular stomatitis virus are due to inhibition of host gene expression. J Virol 77:4658–4669 [CrossRef]
    [Google Scholar]
20. Kopecky S. A., Willingham M. C., Lyles D. S. 2001; Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus. J Virol 75:12169–12181 [CrossRef]
    [Google Scholar]
21. McCormick A. L., Smith V. L., Chow D., Mocarski E. S. 2003; Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J Virol 77:631–641 [CrossRef]
    [Google Scholar]
22. Mossman K., Lee S. F., Barry M., Boshkov L., McFadden G. 1996; Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J Virol 70:4394–4410
    [Google Scholar]
23. Park M.-S., García-Sastre A., Cros J. F., Basler C. F., Palese P. 2003; Newcastle disease virus V protein is a determinant of host range restriction. J Virol 77:9522–9532 [CrossRef]
    [Google Scholar]
24. Petersen J. M., Her L.-S., Varvel V., Lund E., Dahlberg J. E. 2000; The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes. Mol Cell Biol 20:8590–8601 [CrossRef]
    [Google Scholar]
25. Petersen J. M., Her L.-S., Dahlberg J. E. 2001; Multiple vesiculoviral matrix proteins inhibit both nuclear export and import. Proc Natl Acad Sci U S A 98:8590–8595 [CrossRef]
    [Google Scholar]
26. Stojdl D. F., Lichty B. D., tenOever B. R. & 12 other authors 2003; VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4:263–275 [CrossRef]
    [Google Scholar]
27. von Kobbe C., van Deursen J. M. A., Rodrigues J. P., Sitterlin D., Bachi A., Wu X., Wilm M., Carmo-Fonseca M., Izaurralde E. 2000; Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98. Mol Cell 6:1243–1252 [CrossRef]
    [Google Scholar]